MDWD logo

MDWD MediWound Ltd.

NASDAQ · Biotechnology · Healthcare

$13.61
-0.07 (-0.51%)

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn cent…

Market Cap: $175.71Mwww.mediwound.com

Price

No data yet.

Social Signal Score

44
5d
—
30d
43
6 mentions
—
60d
43
6 mentions
—
90d
46
9 mentions
—
news: 9

Analyst Ratings

13 analysts
Buyconsensus
Strong Buy 0Buy 13Hold 0Sell 0Strong Sell 0
Avg price target$28.5+109.4%
Low $27Median $28.5High $30
Current Consensus

Revenue

$3.57M+730.93%
$430.0K$7.20M$13.97M$20.75M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-2.16
$-2.32–$-1.89
5 analysts
FY2026
$-1.99
$-2.28–$-1.70
4 analysts
FY2027
$-2.16
$-2.63–$-1.88
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Ofer Gonen
Sector
Healthcare
Industry
Biotechnology
Employees
121
Beta
0.14
Country
IL
Piotroski score
1 / 9 (Weak)
Altman Z-score
2.35
www.mediwound.com